Picture of Hikma Pharmaceuticals logo

HIK Hikma Pharmaceuticals News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

REG - Hikma Pharmaceutical - Block listing Interim Review <Origin Href="QuoteRef">HIK.L</Origin>

RNS Number : 4241B
Hikma Pharmaceuticals Plc
03 April 2017

Block Listing Six Monthly Return

Information provided on this form must be typed or printed electronically and provided to an RIS.

Date: 3 April 2017

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

&

Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")

&

Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")

&

Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")

Period of return

From:

1 October 2016

To:

31 March 2017

Balance of unallotted securities under scheme(s) from previous return:

SOP: 792,700 ordinary shares of 10 pence

LTIP: 305,031 ordinary shares of 10 pence

MIP: 111,007 ordinary shares of 10 pence

EIP: 0 ordinary shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

SOP: 0 ordinary shares of 10 pence

LTIP: 121,000 ordinary shares of 10 pence

MIP: 200,000 ordinary shares of 10 pence

EIP: 379,000 ordinary shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

SOP: 0 ordinary shares of 10 pence

LTIP: 35,940 ordinary shares of 10 pence

MIP: 393 ordinary shares of 10 pence

EIP: 14,394 ordinary shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

SOP: 792,700 ordinary shares of 10 pence

LTIP: 390,091 ordinary shares of 10 pence

MIP: 310,614 ordinary shares of 10 pence

EIP: 364,606 ordinary shares of 10 pence

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

Stock Option Plan ("SOP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/10/2016

-

-

792,700

Blocklisting return on 01/10/16

01/04/2017

-

-

792,700

Blocklisting return on 01/04/17


Long Term Incentive Plan ("LTIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/10/2016

-

-

305,031

Blocklisting return on 01/04/16

10/10/2016

0

6,463

298,568


23/10/2016

121,000

0

419,568


08/11/2016

0

5,565

414,003


10/11/2016

0

7,964

411,147


14/11/2016

0

6,463

399,576


09/01/2017

0

5,000

394,576


17/03/2017

0

4,485

390,091


01/04/2017

-

-

390,091

Blocklisting return on 01/04/17


Management Incentive Plan ("MIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/10/2016

-

-

111,007

Blocklisting return on 01/10/16

23/10/2016

200,000

0

311,007


16/02/2016

0

393

310,614


01/04/2017

-

-

310,614

Blocklisting return on 01/04/17


Executive Incentive Plan ("EIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/10/2016

-

-

111,007


23/10/2016

379,000

0

379,000


04/01/2017

0

7,775

371,225


05/01/2017

0

3,713

367,512


17/02/2017

0

2,906

364,606


01/04/2017

-

-

364,606

Blocklisting return 01/04/17


This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRUGUWACUPMGCW

Recent news on Hikma Pharmaceuticals

See all news